Table 1
Sex/age | Clinical context | Indication | Haemostasis | rFVIIa | PT after rFVIIa |
|---|---|---|---|---|---|
F/23 years | Cirrhosis, ARF, liver T | Liver T | PT: 30% | ||
FV: 36% | 90 μg/kg × 3 | PT: 100% | |||
M/53 years | PAHT, pulmonary T | Bleeding post lung T | PT: 24% | ||
FV: 13% | 90 μg/kg | PT: 100% | |||
M/60 years | Liver T, aspirin | Adverse event in a liver biopsy | PT: 35% | ||
FV: 37% | 90 μg/kg × 2 | PT: 75% | |||
M/58 years | Fulminant liver failure | Liver T in emergency | PT: 19% | ||
FV: 33% | 90 μg/kg | PT: 100% | |||
M/55 years | Cirrhosis, liver T | Bleeding post liver T | PT: 29% | ||
FV: 41% | 90 μg/kg × 2 | PT: 100% |